No Prescription |
 |
 | ||
|
Mycept S Myfortic |
|
| ||
No Prescription » Prescription Drugs 11 » Mycept S Myfortic Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted kidney. It belongs to a class of medications called immunosuppressants. This medication works by lowering your body's immune system activity.How to use Mycophenolic OralTake this medication as directed usually twice daily on an empty stomach one hour before or two hours after meals.Swallow whole. Do not crush chew or break the tablet. The coating of this tablet allows the drug to be absorbed by your intestines. This product cannot be well absorbed by your stomach.Certain drugs may decrease the amount of mycophenolate that your body absorbs if taken at the same time. Do not take this medication at the same time as antacids containing aluminum and/or magnesium cholestyramine colestipol or calcium-free phosphate binders (e.g. aluminum products lanthanum sevelamer). For more details ask your pharmacist.Use this medication regularly in order to get the most benefit from it. Remember to use it at the same times each day. Dosage is based on your medical condition and response to therapy.Take this medication exactly as prescribed by your doctor. Do not skip any doses. It is very important to continue taking this medication even if you feel well. Do not stop taking mycophenolate without first talking to your doctor.Mycophenolate Oral is used to treat the following:Prevent Kidney Transplant Rejection Buy Mycept S Myfortic and other Prescription Drugs 11 products online at Medstore. Buy Online at Medstore - Click Here!
About Mycept S Myfortic: Product Type: Prescription Drugs 11 Mycept-S ( Myfortic Cellcept Generic Mycophenolic ) Mycept-S (Myfortic Cellcept Generic Mycophenolic) Myfortic Cellcept Generic Mycophenolic 180mg Myfortic Cellcept Generic Mycophenolic Mycept-S
View more Prescription Drugs 11 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
